New aspects in the pathogenesis of diabetic atherothrombosis.
about
Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalA preliminary engineering design of intravascular dual-frequency transducers for contrast-enhanced acoustic angiography and molecular imagingDifferences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasoundHaptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosisVitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotypeDrug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients.Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.Insulin receptor substrate-1 expression is increased in circulating leukocytes of patients with acute coronary syndromeAssociation of the NAD(P)H oxidase p22 phox gene C242T polymorphism with type 2 diabetes mellitus, diabetic nephropathy, and carotid atherosclerosis with type 2 diabetes mellitus: A meta-analysisDifferent impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic RegistryOsteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES).PPAR Agonists and Cardiovascular Disease in Diabetes.High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy.Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes MellitusPolymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes MellitusIs it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.The prospective contribution of hostility characteristics to high fasting glucose levels: the moderating role of marital status.Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortalityImpact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic SyndromeType 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection.Role of Haptoglobin in Health and Disease: A Focus on Diabetes.The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.Atherosclerotic plaque development and instability: a dual role for VEGF.The pathologic continuum of diabetic vascular disease.PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cellsDetermination of the value of glycated hemoglobin HbA1c and fructosamine in assessing the risk of perioperative complications after cardiac surgery in patients with type 2 diabetes.Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients.Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials.Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes.
P2860
Q26827620-24ADAE44-11A1-4B59-99A9-F0A956A242A3Q30411969-E8ED1FAF-C146-461C-AFEE-16D69C0DBC80Q33602359-5F2A6869-A88E-4CD9-A867-3CB13A9EF3EEQ33688005-0D76EC15-DEA6-47FF-8D33-02912D7ACCABQ33718536-D7BB488B-F670-435B-96B5-B8707A47C018Q33759007-8652073C-B2CF-47B5-89F5-E74204126801Q33894052-257D403B-123A-4583-A041-A45209394E68Q35126319-6B4C5C10-4D26-49FD-8EC2-1DD6B70651FEQ35167634-57546217-2B75-46B9-8DD2-7AB7B6A5EB9BQ35411868-8DECB7D7-2754-4AF8-B18C-49500006A09AQ35601594-1B14BE91-06E5-4E11-AE58-F7EA8CD5DF4EQ35684097-ED96A38E-25AA-4CFF-A180-E1F5200825D8Q35684254-3B91F918-B8D7-4231-9C11-B89E3A03F296Q36017360-76AA0FD6-7291-452D-82AD-300F613DA3C8Q36025233-1BB5222B-D803-4DF0-8627-64D949B586A2Q36066531-D534175E-A37B-4B8E-9BEA-9573EA9C5951Q36162995-69E8131B-3674-49CE-BC94-6DF6EF933302Q36262459-691B850E-919E-4EC7-9CE4-1AEDDF26ACF1Q36444975-FF7B361A-AAB3-485B-B6CF-C5223D12D242Q36517414-91891942-24AC-475B-8DED-4CB7FF669EEBQ36529712-A3B0823E-DB52-44FD-9A91-50A2311B05B7Q36582658-C96FAED2-AC34-4AC1-8367-EF7069A2426EQ36664118-2E1C25CE-BF5E-4130-88FA-BD040BB96195Q36691768-7A1BBF1D-27AF-40CF-A2F8-D0C13BA93C07Q36756726-2262B128-4A36-41F1-B121-AE2309507DE7Q36785461-FEE30481-5782-4D52-BF30-B8E07C650296Q36836647-5DEE96F7-FB5D-4F1B-8FEA-EDF5FB6BA69FQ36944112-1CD42DC5-BAD3-4C1B-AF5F-23D0CE933F38Q36982936-2CB114BC-2627-415E-BAEE-8456D20CF64AQ37076469-2B9F5DA2-EBF9-4BAC-9AC0-D23B6A10175BQ37248191-429C46B2-36D5-415F-9F6E-560C2A4B2999Q37306857-E9D21822-D844-4F13-8ADE-D42BBD17A003Q37352918-DE8152CC-E789-4535-BF1B-379B54CECC69Q37380374-3985ED80-839E-4A75-BE66-6F85612952B3Q37421254-D337A21C-356D-451D-AD7E-8C74ADDCAA38Q37584149-03F6CA49-EF6F-44C6-9BDC-B40DC3C61701Q37627874-8616E38D-98FF-4BDF-9F5C-8A6D1D3FDB41Q37664599-27778E1F-815A-47FF-918A-2BB746D1EDAEQ38005018-93CCEEAA-26A8-4C2D-80A1-6A8A4DAE8863Q38369098-66ADA3CD-C5F9-428A-BD1E-75279034F7B2
P2860
New aspects in the pathogenesis of diabetic atherothrombosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New aspects in the pathogenesis of diabetic atherothrombosis.
@ast
New aspects in the pathogenesis of diabetic atherothrombosis.
@en
type
label
New aspects in the pathogenesis of diabetic atherothrombosis.
@ast
New aspects in the pathogenesis of diabetic atherothrombosis.
@en
prefLabel
New aspects in the pathogenesis of diabetic atherothrombosis.
@ast
New aspects in the pathogenesis of diabetic atherothrombosis.
@en
P1476
New aspects in the pathogenesis of diabetic atherothrombosis.
@en
P2093
Pedro R Moreno
P304
P356
10.1016/J.JACC.2004.07.060
P407
P577
2004-12-01T00:00:00Z